Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals Ltd. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Kiniksa Pharmaceuticals Ltd. is not very popular among insiders. Kiniksa Pharmaceuticals Ltd. is a mediocre stock to choose.
Log in to see more information.
Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in discovering, acquiring...
KNSA Fundamental Data by TradingView

News

Los Angeles Capital Management LLC Has $1.48 Million Stock Position in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)
Los Angeles Capital Management LLC Has $1.48 Million Stock Position in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)

Zolmax Los Angeles Capital Management LLC cut its holdings in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA - Free Report) by 43.4% during the 2nd quarter, according to the company in its most recent...\n more…

Los Angeles Capital Management LLC Sells 60,650 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)
Los Angeles Capital Management LLC Sells 60,650 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)

Ticker Report Los Angeles Capital Management LLC lessened its holdings in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA - Free Report) by 43.4% during the second quarter, according to the company in its most recent...\n more…

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Insider John F. Paolini Sells 60,692 Shares
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Insider John F. Paolini Sells 60,692 Shares

Ticker Report Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA - Get Free Report) insider John F. Paolini sold 60,692 shares of the firm's stock in a transaction that occurred on Tuesday, September 3rd. The stock was...\n more…

Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) COO Sells $470,925.00 in Stock
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) COO Sells $470,925.00 in Stock

Zolmax Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA - Get Free Report) COO Eben Tessari sold 17,500 shares of Kiniksa Pharmaceuticals stock in a transaction on Tuesday, August 27th. The stock was sold at an...\n more…

Peregrine Capital Management LLC Acquires 3,111 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)
Peregrine Capital Management LLC Acquires 3,111 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA)

Ticker Report Peregrine Capital Management LLC increased its holdings in Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA - Free Report) by 1.3% in the 2nd quarter, according to the company in its most recent Form 13F...\n more…

Eben Tessari Sells 17,500 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Stock
Eben Tessari Sells 17,500 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Stock

Ticker Report Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA - Get Free Report) COO Eben Tessari sold 17,500 shares of the stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of...\n more…